Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Freeline Therapeutics
Biotech
Syncona merges Freeline, SwanBio into new gene therapy biotech
Spur’s pipeline will feature Freeline’s Gaucher disease program FLT201, as well as SwanBio’s phase 1/2 program for adrenomyeloneuropathy.
James Waldron
Jun 17, 2024 11:01am
Syncona throws lifeline to Freeline by buying struggling biotech
Nov 22, 2023 9:40am
Freeline, facing fading cash runway, mulls buyout by Syncona
Oct 19, 2023 10:00am
Freeline cans another 30% of its staff months after last layoffs
Apr 4, 2023 8:45am
Syncona blames biotech bear market for 'disappointing' returns
Feb 7, 2023 10:31am
Adamis, Harpoon, Neoleukin and Tricida grow biotech layoff wave
Nov 15, 2022 6:45am
